Literature DB >> 18381906

Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients.

Philip Gorwood1, Emmanuelle Corruble, Bruno Falissard, Guy M Goodwin.   

Abstract

OBJECTIVE: An important current hypothesis suggests that the relationship between severe depression and the hippocampus is essentially toxic. The purpose of this study was to assess the generalizability of the impact of depression on hippocampal function.
METHOD: Participants were 8,229 outpatients who 1) fulfilled DSM-IV criteria for major depressive disorder based on clinical assessment and 2) were tested for delayed recall, a memory function that is particularly related to hippocampal integrity in humans, during two visits several weeks apart.
RESULTS: As expected, at presentation with depression, the subjects' current illness severity was the major determinant of performance, as opposed to the intensity of their previous depressive history (the number and length of past episodes). However, following clinical response at the second visit, the length of previous depressive history became more significant than current symptoms. The following factors had significant, independent impact: age, education level, and profession.
CONCLUSIONS: Previous studies of small samples assessed for memory function, more or less specific to the hippocampus, have shown great variability in age, gender, education level, and the length and intensity of depressive episode. Hence, a very large sample was required to disentangle the central effect of previous depressive history. As demonstrated in a general practice sample in this study, the hypothesis that the length of past depression impairs memory performance is supported, suggesting that there is a toxic link between the burden of depression and cognition. This finding has important implications for public health.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18381906     DOI: 10.1176/appi.ajp.2008.07040574

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  39 in total

1.  Impaired sustained attention and executive dysfunction: bipolar disorder versus depression-specific markers of affective disorders.

Authors:  Fadi T Maalouf; Crystal Klein; Luke Clark; Barbara J Sahakian; Edmund J Labarbara; Amelia Versace; Stefanie Hassel; Jorge R C Almeida; Mary L Phillips
Journal:  Neuropsychologia       Date:  2010-02-20       Impact factor: 3.139

2.  Marijuana use and major depressive disorder are additively associated with reduced verbal learning and altered cortical thickness.

Authors:  Milena Radoman; Susanne S Hoeppner; Randi M Schuster; A Eden Evins; Jodi M Gilman
Journal:  Cogn Affect Behav Neurosci       Date:  2019-08       Impact factor: 3.282

Review 3.  Interoception and Inflammation in Psychiatric Disorders.

Authors:  Jonathan Savitz; Neil A Harrison
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-01-09

Review 4.  Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors.

Authors:  Thomas Beblo; Grant Sinnamon; Bernhard T Baune
Journal:  Neuropsychol Rev       Date:  2011-06-10       Impact factor: 7.444

5.  Spousal loss and cognitive function in later life: a 25-year follow-up in the AGES-Reykjavik study.

Authors:  Halldora Vidarsdottir; Fang Fang; Milan Chang; Thor Aspelund; Katja Fall; Maria K Jonsdottir; Palmi V Jonsson; Mary Frances Cotch; Tamara B Harris; Lenore J Launer; Vilmundur Gudnason; Unnur Valdimarsdottir
Journal:  Am J Epidemiol       Date:  2014-01-19       Impact factor: 4.897

6.  Efficacy of an intervention for families living with HIV in Thailand: a randomized controlled trial.

Authors:  Li Li; Li-Jung Liang; Sung-Jae Lee; Sopon Iamsirithaworn; Dai Wan; Mary Jane Rotheram-Borus
Journal:  AIDS Behav       Date:  2012-07

Review 7.  Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years.

Authors:  G Voegeli; M L Cléry-Melin; N Ramoz; P Gorwood
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

Review 8.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 9.  Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression.

Authors:  Jing Wang; Liang Jing; Juan-Carlos Toledo-Salas; Lin Xu
Journal:  Neurosci Bull       Date:  2014-12-06       Impact factor: 5.203

10.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.